Pharmaceuticals

Former CDC Director Julie Gerberding Joins Merck as Vaccine Division President

2009-12-21 00:00:00 +0000 UTC | Importance: 8/10

Dr. Julie Gerberding, who served as CDC Director from 2002-2009, joined Merck as president of the company’s vaccine division shortly after leaving government service. This move sparked significant controversy because during her tenure at the CDC, Gerberding oversaw the agency’s …

Dr. Julie Gerberding CDC Merck Gardasil vaccine regulatory-capture cdc pharmaceuticals revolving-door vaccines +1 more

FDA Whistleblower David Graham Testifies on Vioxx Cover-up Before Senate

2004-11-18 00:00:00 +0000 UTC | Importance: 9/10

FDA epidemiologist Dr. David Graham delivered explosive testimony before the U.S. Senate Finance Committee, declaring that ’the FDA, as currently configured, is incapable of protecting America against another Vioxx. We are virtually defenseless.’ Graham revealed that his study showed …

Dr. David Graham FDA Merck U.S. Senate Finance Committee Government Accountability Project regulatory-capture fda pharmaceuticals whistleblower vioxx +2 more

FDA Approves OxyContin with Unsubstantiated Safety Claims

1995-12-20 00:00:00 +0000 UTC | Importance: 9/10

The FDA approved Purdue Pharma’s OxyContin application, including a scientifically unsubstantiated claim that delayed absorption ‘is believed to reduce the abuse liability of a drug.’ This approval occurred without clinical trials to prove the safety claim and marked the beginning …

FDA Purdue Pharma Dr. Curtis Wright Sackler Family regulatory-capture fda pharmaceuticals opioid-crisis revolving-door +1 more